← 產業報告目錄
Pulmonary Arterial Hypertension Equipment Industry Research Report 2026
出版商 APO Research產業別 Medical Devices出版日期 2026-07-04頁數 120報告編號 APO-e2571e2837
授權報價
| Single User | $2,950 USD |
| Multi User | $4,430 USD |
| Enterprise | $5,900 USD |
報告摘要
The global Pulmonary Arterial Hypertension Equipment market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Pulmonary Arterial Hypertension Equipment is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Pulmonary Arterial Hypertension Equipment is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
The Asia Pacific market for Pulmonary Arterial Hypertension Equipment is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Pulmonary Arterial Hypertension Equipment include Medtronic, V-Wave Ltd, Swan-Ganz, SoniVie, Smiths Medical, Pulnovo Medical (Wuxi) Co.,Ltd., Philips, Nonin Medical and Masimo, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Pulmonary Arterial Hypertension Equipment market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pulmonary Arterial Hypertension Equipment Market by Company
Medtronic
V-Wave Ltd
Swan-Ganz
SoniVie
Smiths Medical
Pulnovo Medical (Wuxi) Co.,Ltd.
Philips
Nonin Medical
Masimo
GE Healthcare
Aria CV
Pulmonary Arterial Hypertension Equipment Segment by Type
Diagnostic Equipment
Treatment Equipment
Pulmonary Arterial Hypertension Equipment Segment by Application
Home Care
Hospital
Clinic
Pulmonary Arterial Hypertension Equipment Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pulmonary Arterial Hypertension Equipment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pulmonary Arterial Hypertension Equipment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pulmonary Arterial Hypertension Equipment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Pulmonary Arterial Hypertension Equipment manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Pulmonary Arterial Hypertension Equipment by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Pulmonary Arterial Hypertension Equipment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
目錄 Table of Contents
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Pulmonary Arterial Hypertension Equipment Market Size (2021-2032)
2.2.2 Global Pulmonary Arterial Hypertension Equipment Sales (2021-2032)
2.2.3 Global Pulmonary Arterial Hypertension Equipment Market Average Price (2021-2032)
2.3 Pulmonary Arterial Hypertension Equipment by Type
2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
2.3.2 Diagnostic Equipment
2.3.3 Treatment Equipment
2.4 Pulmonary Arterial Hypertension Equipment by Application
2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
2.4.2 Home Care
2.4.3 Hospital
2.4.4 Clinic
3 Market Competitive Landscape by Manufacturers
3.1 Global Pulmonary Arterial Hypertension Equipment Market Competitive Situation by Manufacturers (2021 Versus 2025)
3.2 Global Pulmonary Arterial Hypertension Equipment Sales (k units) of Manufacturers (2021-2026)
3.3 Global Pulmonary Arterial Hypertension Equipment Revenue of Manufacturers (2021-2026)
3.4 Global Pulmonary Arterial Hypertension Equipment Average Price by Manufacturers (2021-2026)
3.5 Global Pulmonary Arterial Hypertension Equipment Industry Ranking, 2024 VS 2025 VS 2026
3.6 Global Manufacturers of Pulmonary Arterial Hypertension Equipment, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Pulmonary Arterial Hypertension Equipment, Product Type & Application
3.8 Global Manufacturers of Pulmonary Arterial Hypertension Equipment, Established Date
3.9 Global Pulmonary Arterial Hypertension Equipment Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Medtronic
4.1.1 Medtronic Company Information
4.1.2 Medtronic Business Overview
4.1.3 Medtronic Pulmonary Arterial Hypertension Equipment Sales, Revenue and Gross Margin (2021-2026)
4.1.4 Medtronic Pulmonary Arterial Hypertension Equipment Product Portfolio
4.1.5 Medtronic Recent Developments
4.2 V-Wave Ltd
4.2.1 V-Wave Ltd Company Information
4.2.2 V-Wave Ltd Business Overview
4.2.3 V-Wave Ltd Pulmonary Arterial Hypertension Equipment Sales, Revenue and Gross Margin (2021-2026)
4.2.4 V-Wave Ltd Pulmonary Arterial Hypertension Equipment Product Portfolio
4.2.5 V-Wave Ltd Recent Developments
4.3 Swan-Ganz
4.3.1 Swan-Ganz Company Information
4.3.2 Swan-Ganz Business Overview
4.3.3 Swan-Ganz Pulmonary Arterial Hypertension Equipment Sales, Revenue and Gross Margin (2021-2026)
4.3.4 Swan-Ganz Pulmonary Arterial Hypertension Equipment Product Portfolio
4.3.5 Swan-Ganz Recent Developments
4.4 SoniVie
4.4.1 SoniVie Company Information
4.4.2 SoniVie Business Overview
4.4.3 SoniVie Pulmonary Arterial Hypertension Equipment Sales, Revenue and Gross Margin (2021-2026)
4.4.4 SoniVie Pulmonary Arterial Hypertension Equipment Product Portfolio
4.4.5 SoniVie Recent Developments
4.5 Smiths Medical
4.5.1 Smiths Medical Company Information
4.5.2 Smiths Medical Business Overview
4.5.3 Smiths Medical Pulmonary Arterial Hypertension Equipment Sales, Revenue and Gross Margin (2021-2026)
4.5.4 Smiths Medical Pulmonary Arterial Hypertension Equipment Product Portfolio
4.5.5 Smiths Medical Recent Developments
4.6 Pulnovo Medical (Wuxi) Co.,Ltd.
4.6.1 Pulnovo Medical (Wuxi) Co.,Ltd. Company Information
4.6.2 Pulnovo Medical (Wuxi) Co.,Ltd. Business Overview
4.6.3 Pulnovo Medical (Wuxi) Co.,Ltd. Pulmonary Arterial Hypertension Equipment Sales, Revenue and Gross Margin (2021-2026)
4.6.4 Pulnovo Medical (Wuxi) Co.,Ltd. Pulmonary Arterial Hypertension Equipment Product Portfolio
4.6.5 Pulnovo Medical (Wuxi) Co.,Ltd. Recent Developments
4.7 Philips
4.7.1 Philips Company Information
4.7.2 Philips Business Overview
4.7.3 Philips Pulmonary Arterial Hypertension Equipment Sales, Revenue and Gross Margin (2021-2026)
4.7.4 Philips Pulmonary Arterial Hypertension Equipment Product Portfolio
4.7.5 Philips Recent Developments
4.8 Nonin Medical
4.8.1 Nonin Medical Company Information
4.8.2 Nonin Medical Business Overview
4.8.3 Nonin Medical Pulmonary Arterial Hypertension Equipment Sales, Revenue and Gross Margin (2021-2026)
4.8.4 Nonin Medical Pulmonary Arterial Hypertension Equipment Product Portfolio
4.8.5 Nonin Medical Recent Developments
4.9 Masimo
4.9.1 Masimo Company Information
4.9.2 Masimo Business Overview
4.9.3 Masimo Pulmonary Arterial Hypertension Equipment Sales, Revenue and Gross Margin (2021-2026)
4.9.4 Masimo Pulmonary Arterial Hypertension Equipment Product Portfolio
4.9.5 Masimo Recent Developments
4.10 GE Healthcare
4.10.1 GE Healthcare Company Information
4.10.2 GE Healthcare Business Overview
4.10.3 GE Healthcare Pulmonary Arterial Hypertension Equipment Sales, Revenue and Gross Margin (2021-2026)
4.10.4 GE Healthcare Pulmonary Arterial Hypertension Equipment Product Portfolio
4.10.5 GE Healthcare Recent Developments
4.11 Aria CV
4.11.1 Aria CV Company Information
4.11.2 Aria CV Business Overview
4.11.3 Aria CV Pulmonary Arterial Hypertension Equipment Sales, Revenue and Gross Margin (2021-2026)
4.11.4 Aria CV Pulmonary Arterial Hypertension Equipment Product Portfolio
4.11.5 Aria CV Recent Developments
5 Global Pulmonary Arterial Hypertension Equipment Market Scenario by Region
5.1 Global Pulmonary Arterial Hypertension Equipment Market Size by Region: 2021 VS 2025 VS 2032
5.2 Global Pulmonary Arterial Hypertension Equipment Sales by Region: 2021-2032
5.2.1 Global Pulmonary Arterial Hypertension Equipment Sales by Region: 2021-2026
5.2.2 Global Pulmonary Arterial Hypertension Equipment Sales by Region: 2027-2032
5.3 Global Pulmonary Arterial Hypertension Equipment Revenue by Region: 2021-2032
5.3.1 Global Pulmonary Arterial Hypertension Equipment Revenue by Region: 2021-2026
5.3.2 Global Pulmonary Arterial Hypertension Equipment Revenue by Region: 2027-2032
5.4 North America Pulmonary Arterial Hypertension Equipment Market Facts & Figures by Country
5.4.1 North America Pulmonary Arterial Hypertension Equipment Market Size by Country: 2021 VS 2025 VS 2032
5.4.2 North America Pulmonary Arterial Hypertension Equipment Sales by Country (2021-2032)
5.4.3 North America Pulmonary Arterial Hypertension Equipment Revenue by Country (2021-2032)
5.4.4 United States
5.4.5 Canada
5.4.6 Mexico
5.5 Europe Pulmonary Arterial Hypertension Equipment Market Facts & Figures by Country
5.5.1 Europe Pulmonary Arterial Hypertension Equipment Market Size by Country: 2021 VS 2025 VS 2032
5.5.2 Europe Pulmonary Arterial Hypertension Equipment Sales by Country (2021-2032)
5.5.3 Europe Pulmonary Arterial Hypertension Equipment Revenue by Country (2021-2032)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.5.9 Spain
5.5.10 Netherlands
5.5.11 Switzerland
5.5.12 Sweden
5.5.13 Poland
5.6 Asia Pacific Pulmonary Arterial Hypertension Equipment Market Facts & Figures by Country
5.6.1 Asia Pacific Pulmonary Arterial Hypertension Equipment Market Size by Country: 2021 VS 2025 VS 2032
5.6.2 Asia Pacific Pulmonary Arterial Hypertension Equipment Sales by Country (2021-2032)
5.6.3 Asia Pacific Pulmonary Arterial Hypertension Equipment Revenue by Country (2021-2032)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 Taiwan
5.6.10 Southeast Asia
5.7 South America Pulmonary Arterial Hypertension Equipment Market Facts & Figures by Country
5.7.1 South America Pulmonary Arterial Hypertension Equipment Market Size by Country: 2021 VS 2025 VS 2032
5.7.2 South America Pulmonary Arterial Hypertension Equipment Sales by Country (2021-2032)
5.7.3 South America Pulmonary Arterial Hypertension Equipment Revenue by Country (2021-2032)
5.7.4 Brazil
5.7.5 Argentina
5.7.6 Chile
5.8 Middle East and Africa Pulmonary Arterial Hypertension Equipment Market Facts & Figures by Country
5.8.1 Middle East and Africa Pulmonary Arterial Hypertension Equipment Market Size by Country: 2021 VS 2025 VS 2032
5.8.2 Middle East and Africa Pulmonary Arterial Hypertension Equipment Sales by Country (2021-2032)
5.8.3 Middle East and Africa Pulmonary Arterial Hypertension Equipment Revenue by Country (2021-2032)
5.8.4 Egypt
5.8.5 South Africa
5.8.6 Israel
5.8.7 Türkiye
5.8.8 GCC Countries
6 Segment by Type
6.1 Global Pulmonary Arterial Hypertension Equipment Sales by Type (2021-2032)
6.1.1 Global Pulmonary Arterial Hypertension Equipment Sales by Type (2021-2032) & (k units)
6.1.2 Global Pulmonary Arterial Hypertension Equipment Sales Market Share by Type (2021-2032)
6.2 Global Pulmonary Arterial Hypertension Equipment Revenue by Type (2021-2032)
6.2.1 Global Pulmonary Arterial Hypertension Equipment Sales by Type (2021-2032) & (US$ Million)
6.2.2 Global Pulmonary Arterial Hypertension Equipment Revenue Market Share by Type (2021-2032)
6.3 Global Pulmonary Arterial Hypertension Equipment Price by Type (2021-2032)
7 Segment by Application
7.1 Global Pulmonary Arterial Hypertension Equipment Sales by Application (2021-2032)
7.1.1 Global Pulmonary Arterial Hypertension Equipment Sales by Application (2021-2032) & (k units)
7.1.2 Global Pulmonary Arterial Hypertension Equipment Sales Market Share by Application (2021-2032)
7.2 Global Pulmonary Arterial Hypertension Equipment Revenue by Application (2021-2032)
7.2.1 Global Pulmonary Arterial Hypertension Equipment Sales by Application (2021-2032) & (US$ Million)
7.2.2 Global Pulmonary Arterial Hypertension Equipment Revenue Market Share by Application (2021-2032)
7.3 Global Pulmonary Arterial Hypertension Equipment Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Pulmonary Arterial Hypertension Equipment Value Chain Analysis
8.1.1 Pulmonary Arterial Hypertension Equipment Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Pulmonary Arterial Hypertension Equipment Production Mode & Process
8.2 Pulmonary Arterial Hypertension Equipment Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Pulmonary Arterial Hypertension Equipment Distributors
8.2.3 Pulmonary Arterial Hypertension Equipment Customers
9 Global Pulmonary Arterial Hypertension Equipment Analyzing Market Dynamics
9.1 Pulmonary Arterial Hypertension Equipment Industry Trends
9.2 Pulmonary Arterial Hypertension Equipment Industry Drivers
9.3 Pulmonary Arterial Hypertension Equipment Industry Opportunities and Challenges
9.4 Pulmonary Arterial Hypertension Equipment Industry Restraints
10 Report Conclusion
11 Disclaimer
圖表清單 List of Tables & Figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Pulmonary Arterial Hypertension Equipment Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025)
Table 6. Global Pulmonary Arterial Hypertension Equipment Sales (k units) of Manufacturers (2021-2026)
Table 7. Global Pulmonary Arterial Hypertension Equipment Sales Market Share by Manufacturers (2021-2026)
Table 8. Global Pulmonary Arterial Hypertension Equipment Revenue of Manufacturers (2021-2026)
Table 9. Global Pulmonary Arterial Hypertension Equipment Revenue Share by Manufacturers (2021-2026)
Table 10. Global Market Pulmonary Arterial Hypertension Equipment Average Price (USD/unit) of Manufacturers (2021-2026)
Table 11. Global Pulmonary Arterial Hypertension Equipment Industry Ranking, 2024 VS 2025 VS 2026
Table 12. Global Manufacturers of Pulmonary Arterial Hypertension Equipment, Manufacturing Sites & Headquarters
Table 13. Global Manufacturers of Pulmonary Arterial Hypertension Equipment, Product Type & Application
Table 14. Global Pulmonary Arterial Hypertension Equipment Manufacturers Established Date
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Pulmonary Arterial Hypertension Equipment by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 18. Medtronic Company Information
Table 19. Medtronic Business Overview
Table 20. Medtronic Pulmonary Arterial Hypertension Equipment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 21. Medtronic Pulmonary Arterial Hypertension Equipment Product Portfolio
Table 22. Medtronic Recent Developments
Table 23. V-Wave Ltd Company Information
Table 24. V-Wave Ltd Business Overview
Table 25. V-Wave Ltd Pulmonary Arterial Hypertension Equipment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 26. V-Wave Ltd Pulmonary Arterial Hypertension Equipment Product Portfolio
Table 27. V-Wave Ltd Recent Developments
Table 28. Swan-Ganz Company Information
Table 29. Swan-Ganz Business Overview
Table 30. Swan-Ganz Pulmonary Arterial Hypertension Equipment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 31. Swan-Ganz Pulmonary Arterial Hypertension Equipment Product Portfolio
Table 32. Swan-Ganz Recent Developments
Table 33. SoniVie Company Information
Table 34. SoniVie Business Overview
Table 35. SoniVie Pulmonary Arterial Hypertension Equipment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 36. SoniVie Pulmonary Arterial Hypertension Equipment Product Portfolio
Table 37. SoniVie Recent Developments
Table 38. Smiths Medical Company Information
Table 39. Smiths Medical Business Overview
Table 40. Smiths Medical Pulmonary Arterial Hypertension Equipment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 41. Smiths Medical Pulmonary Arterial Hypertension Equipment Product Portfolio
Table 42. Smiths Medical Recent Developments
Table 43. Pulnovo Medical (Wuxi) Co.,Ltd. Company Information
Table 44. Pulnovo Medical (Wuxi) Co.,Ltd. Business Overview
Table 45. Pulnovo Medical (Wuxi) Co.,Ltd. Pulmonary Arterial Hypertension Equipment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 46. Pulnovo Medical (Wuxi) Co.,Ltd. Pulmonary Arterial Hypertension Equipment Product Portfolio
Table 47. Pulnovo Medical (Wuxi) Co.,Ltd. Recent Developments
Table 48. Philips Company Information
Table 49. Philips Business Overview
Table 50. Philips Pulmonary Arterial Hypertension Equipment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 51. Philips Pulmonary Arterial Hypertension Equipment Product Portfolio
Table 52. Philips Recent Developments
Table 53. Nonin Medical Company Information
Table 54. Nonin Medical Business Overview
Table 55. Nonin Medical Pulmonary Arterial Hypertension Equipment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 56. Nonin Medical Pulmonary Arterial Hypertension Equipment Product Portfolio
Table 57. Nonin Medical Recent Developments
Table 58. Masimo Company Information
Table 59. Masimo Business Overview
Table 60. Masimo Pulmonary Arterial Hypertension Equipment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 61. Masimo Pulmonary Arterial Hypertension Equipment Product Portfolio
Table 62. Masimo Recent Developments
Table 63. GE Healthcare Company Information
Table 64. GE Healthcare Business Overview
Table 65. GE Healthcare Pulmonary Arterial Hypertension Equipment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 66. GE Healthcare Pulmonary Arterial Hypertension Equipment Product Portfolio
Table 67. GE Healthcare Recent Developments
Table 68. Aria CV Company Information
Table 69. Aria CV Business Overview
Table 70. Aria CV Pulmonary Arterial Hypertension Equipment Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 71. Aria CV Pulmonary Arterial Hypertension Equipment Product Portfolio
Table 72. Aria CV Recent Developments
Table 73. Global Pulmonary Arterial Hypertension Equipment Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 74. Global Pulmonary Arterial Hypertension Equipment Sales by Region (2021-2026) & (k units)
Table 75. Global Pulmonary Arterial Hypertension Equipment Sales Market Share by Region (2021-2026)
Table 76. Global Pulmonary Arterial Hypertension Equipment Sales by Region (2027-2032) & (k units)
Table 77. Global Pulmonary Arterial Hypertension Equipment Sales Market Share by Region (2027-2032)
Table 78. Global Pulmonary Arterial Hypertension Equipment Revenue by Region (2021-2026) & (US$ Million)
Table 79. Global Pulmonary Arterial Hypertension Equipment Revenue Market Share by Region (2021-2026)
Table 80. Global Pulmonary Arterial Hypertension Equipment Revenue by Region (2027-2032) & (US$ Million)
Table 81. Global Pulmonary Arterial Hypertension Equipment Revenue Market Share by Region (2027-2032)
Table 82. North America Pulmonary Arterial Hypertension Equipment Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 83. North America Pulmonary Arterial Hypertension Equipment Sales by Country (2021-2026) & (k units)
Table 84. North America Pulmonary Arterial Hypertension Equipment Sales by Country (2027-2032) & (k units)
Table 85. North America Pulmonary Arterial Hypertension Equipment Revenue by Country (2021-2026) & (US$ Million)
Table 86. North America Pulmonary Arterial Hypertension Equipment Revenue by Country (2027-2032) & (US$ Million)
Table 87. Europe Pulmonary Arterial Hypertension Equipment Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 88. Europe Pulmonary Arterial Hypertension Equipment Sales by Country (2021-2026) & (k units)
Table 89. Europe Pulmonary Arterial Hypertension Equipment Sales by Country (2027-2032) & (k units)
Table 90. Europe Pulmonary Arterial Hypertension Equipment Revenue by Country (2021-2026) & (US$ Million)
Table 91. Europe Pulmonary Arterial Hypertension Equipment Revenue by Country (2027-2032) & (US$ Million)
Table 92. Asia Pacific Pulmonary Arterial Hypertension Equipment Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 93. Asia Pacific Pulmonary Arterial Hypertension Equipment Sales by Country (2021-2026) & (k units)
Table 94. Asia Pacific Pulmonary Arterial Hypertension Equipment Sales by Country (2027-2032) & (k units)
Table 95. Asia Pacific Pulmonary Arterial Hypertension Equipment Revenue by Country (2021-2026) & (US$ Million)
Table 96. Asia Pacific Pulmonary Arterial Hypertension Equipment Revenue by Country (2027-2032) & (US$ Million)
Table 97. South America Pulmonary Arterial Hypertension Equipment Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 98. South America Pulmonary Arterial Hypertension Equipment Sales by Country (2021-2026) & (k units)
Table 99. South America Pulmonary Arterial Hypertension Equipment Sales by Country (2027-2032) & (k units)
Table 100. South America Pulmonary Arterial Hypertension Equipment Revenue by Country (2021-2026) & (US$ Million)
Table 101. South America Pulmonary Arterial Hypertension Equipment Revenue by Country (2027-2032) & (US$ Million)
Table 102. Middle East and Africa Pulmonary Arterial Hypertension Equipment Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 103. Middle East and Africa Pulmonary Arterial Hypertension Equipment Sales by Country (2021-2026) & (k units)
Table 104. Middle East and Africa Pulmonary Arterial Hypertension Equipment Sales by Country (2027-2032) & (k units)
Table 105. Middle East and Africa Pulmonary Arterial Hypertension Equipment Revenue by Country (2021-2026) & (US$ Million)
Table 106. Middle East and Africa Pulmonary Arterial Hypertension Equipment Revenue by Country (2027-2032) & (US$ Million)
Table 107. Global Pulmonary Arterial Hypertension Equipment Sales by Type (2021-2026) & (k units)
Table 108. Global Pulmonary Arterial Hypertension Equipment Sales by Type (2027-2032) & (k units)
Table 109. Global Pulmonary Arterial Hypertension Equipment Sales Market Share by Type (2021-2026)
Table 110. Global Pulmonary Arterial Hypertension Equipment Sales Market Share by Type (2027-2032)
Table 111. Global Pulmonary Arterial Hypertension Equipment Revenue by Type (2021-2026) & (US$ Million)
Table 112. Global Pulmonary Arterial Hypertension Equipment Revenue by Type (2027-2032) & (US$ Million)
Table 113. Global Pulmonary Arterial Hypertension Equipment Revenue Market Share by Type (2021-2026)
Table 114. Global Pulmonary Arterial Hypertension Equipment Revenue Market Share by Type (2027-2032)
Table 115. Global Pulmonary Arterial Hypertension Equipment Price by Type (2021-2026) & (USD/unit)
Table 116. Global Pulmonary Arterial Hypertension Equipment Price by Type (2027-2032) & (USD/unit)
Table 117. Global Pulmonary Arterial Hypertension Equipment Sales by Application (2021-2026) & (k units)
Table 118. Global Pulmonary Arterial Hypertension Equipment Sales by Application (2027-2032) & (k units)
Table 119. Global Pulmonary Arterial Hypertension Equipment Sales Market Share by Application (2021-2026)
Table 120. Global Pulmonary Arterial Hypertension Equipment Sales Market Share by Application (2027-2032)
Table 121. Global Pulmonary Arterial Hypertension Equipment Revenue by Application (2021-2026) & (US$ Million)
Table 122. Global Pulmonary Arterial Hypertension Equipment Revenue by Application (2027-2032) & (US$ Million)
Table 123. Global Pulmonary Arterial Hypertension Equipment Revenue Market Share by Application (2021-2026)
Table 124. Global Pulmonary Arterial Hypertension Equipment Revenue Market Share by Application (2027-2032)
Table 125. Global Pulmonary Arterial Hypertension Equipment Price by Application (2021-2026) & (USD/unit)
Table 126. Global Pulmonary Arterial Hypertension Equipment Price by Application (2027-2032) & (USD/unit)
Table 127. Key Raw Materials
Table 128. Raw Materials Key Suppliers
Table 129. Pulmonary Arterial Hypertension Equipment Distributors List
Table 130. Pulmonary Arterial Hypertension Equipment Customers List
Table 131. Pulmonary Arterial Hypertension Equipment Industry Trends
Table 132. Pulmonary Arterial Hypertension Equipment Industry Drivers
Table 133. Pulmonary Arterial Hypertension Equipment Industry Restraints
Table 134. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Pulmonary Arterial Hypertension Equipment Product Image
Figure 5. Global Pulmonary Arterial Hypertension Equipment Revenue (US$ Million), 2021 VS 2025 VS 2032
Figure 6. Global Pulmonary Arterial Hypertension Equipment Market Size (2021-2032) & (US$ Million)
Figure 7. Global Pulmonary Arterial Hypertension Equipment Sales (2021-2032) & (k units)
Figure 8. Global Pulmonary Arterial Hypertension Equipment Average Price (USD/unit) & (2021-2032)
Figure 9. Diagnostic Equipment Product Image
Figure 10. Treatment Equipment Product Image
Figure 11. Home Care Product Image
Figure 12. Hospital Product Image
Figure 13. Clinic Product Image
Figure 14. Global Pulmonary Arterial Hypertension Equipment Revenue Share by Manufacturers in 2025
Figure 15. Global Manufacturers of Pulmonary Arterial Hypertension Equipment, Manufacturing Sites & Headquarters
Figure 16. Global Top 5 and 10 Pulmonary Arterial Hypertension Equipment Players Market Share by Revenue in 2025
Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 18. Global Pulmonary Arterial Hypertension Equipment Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Figure 19. Global Pulmonary Arterial Hypertension Equipment Sales by Region in 2025
Figure 20. Global Pulmonary Arterial Hypertension Equipment Revenue by Region in 2025
Figure 21. North America Pulmonary Arterial Hypertension Equipment Market Size by Country in 2025
Figure 22. North America Pulmonary Arterial Hypertension Equipment Sales Market Share by Country (2021-2032)
Figure 23. North America Pulmonary Arterial Hypertension Equipment Revenue Market Share by Country (2021-2032)
Figure 24. United States Pulmonary Arterial Hypertension Equipment Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 25. Canada Pulmonary Arterial Hypertension Equipment Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 26. Mexico Pulmonary Arterial Hypertension Equipment Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 27. Europe Pulmonary Arterial Hypertension Equipment Market Size by Country in 2025
Figure 28. Europe Pulmonary Arterial Hypertension Equipment Sales Market Share by Country (2021-2032)
Figure 29. Europe Pulmonary Arterial Hypertension Equipment Revenue Market Share by Country (2021-2032)
Figure 30. Germany Pulmonary Arterial Hypertension Equipment Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 31. France Pulmonary Arterial Hypertension Equipment Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 32. U.K. Pulmonary Arterial Hypertension Equipment Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 33. Italy Pulmonary Arterial Hypertension Equipment Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 34. Russia Pulmonary Arterial Hypertension Equipment Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 35. Spain Pulmonary Arterial Hypertension Equipment Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 36. Netherlands Pulmonary Arterial Hypertension Equipment Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 37. Switzerland Pulmonary Arterial Hypertension Equipment Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 38. Sweden Pulmonary Arterial Hypertension Equipment Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 39. Poland Pulmonary Arterial Hypertension Equipment Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 40. Asia Pacific Pulmonary Arterial Hypertension Equipment Market Size by Country in 2025
Figure 41. Asia Pacific Pulmonary Arterial Hypertension Equipment Sales Market Share by Country (2021-2032)
Figure 42. Asia Pacific Pulmonary Arterial Hypertension Equipment Revenue Market Share by Country (2021-2032)
Figure 43. China Pulmonary Arterial Hypertension Equipment Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 44. Japan Pulmonary Arterial Hypertension Equipment Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 45. South Korea Pulmonary Arterial Hypertension Equipment Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 46. India Pulmonary Arterial Hypertension Equipment Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 47. Australia Pulmonary Arterial Hypertension Equipment Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 48. Taiwan Pulmonary Arterial Hypertension Equipment Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 49. Southeast Asia Pulmonary Arterial Hypertension Equipment Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 50. Southeast Asia Pulmonary Arterial Hypertension Equipment Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 51. South America Pulmonary Arterial Hypertension Equipment Market Size by Country in 2025
Figure 52. South America Pulmonary Arterial Hypertension Equipment Sales Market Share by Country (2021-2032)
Figure 53. South America Pulmonary Arterial Hypertension Equipment Revenue Market Share by Country (2021-2032)
Figure 54. Brazil Pulmonary Arterial Hypertension Equipment Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 55. Argentina Pulmonary Arterial Hypertension Equipment Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 56. Chile Pulmonary Arterial Hypertension Equipment Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 57. Middle East and Africa Pulmonary Arterial Hypertension Equipment Market Size by Country in 2025
Figure 58. Middle East and Africa Pulmonary Arterial Hypertension Equipment Sales Market Share by Country (2021-2032)
Figure 59. Middle East and Africa Pulmonary Arterial Hypertension Equipment Revenue Market Share by Country (2021-2032)
Figure 60. Egypt Pulmonary Arterial Hypertension Equipment Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 61. South Africa Pulmonary Arterial Hypertension Equipment Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 62. Israel Pulmonary Arterial Hypertension Equipment Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 63. Türkiye Pulmonary Arterial Hypertension Equipment Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 64. GCC Countries Pulmonary Arterial Hypertension Equipment Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 65. Global Pulmonary Arterial Hypertension Equipment Sales Market Share by Type (2021-2032)
Figure 66. Global Pulmonary Arterial Hypertension Equipment Revenue Market Share by Type (2021-2032)
Figure 67. Global Pulmonary Arterial Hypertension Equipment Price (USD/unit) by Type (2021-2032)
Figure 68. Global Pulmonary Arterial Hypertension Equipment Sales Market Share by Application (2021-2032)
Figure 69. Global Pulmonary Arterial Hypertension Equipment Revenue Market Share by Application (2021-2032)
Figure 70. Global Pulmonary Arterial Hypertension Equipment Price (USD/unit) by Application (2021-2032)
Figure 71. Pulmonary Arterial Hypertension Equipment Value Chain
Figure 72. Pulmonary Arterial Hypertension Equipment Production Mode & Process
Figure 73. Direct Comparison with Distribution Share
Figure 74. Distributors Profiles
Figure 75. Pulmonary Arterial Hypertension Equipment Industry Opportunities and Challenges
提及公司
MedtronicV-Wave LtdSwan-GanzSoniVieSmiths MedicalPulnovo Medical (Wuxi) Co.,Ltd.PhilipsNonin MedicalMasimoGE HealthcareAria CV
量子訊息有限公司為 APO Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們